I-025

Interference Mix 3 (For Qualitative Use Only)

50-1000 μg/mL each component in acetonitrile, analytical standard, Cerilliant^®

• 同義詞: Qualitative Interference Mixture
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• 等級: analytical standard
• 形狀: liquid
• 成份: Aripiprazole, 100 μg/mL ; Lacosamide, 100 μg/mL ; Oxcarbazepine, 100 μg/mL ; (+)-Propoxyphene, 50 μg/mL ; Rufinamide, 100 μg/mL ; Warfarin, 1000 μg/mL
• 包裝: ampule of 1 mL
• 製造商／商標名: Cerilliant^®
• drug control: estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
• 濃度: 50-1000 μg/mL each component in acetonitrile
• 技術: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 應用: forensics and toxicology
• 形式: multi-component solution
• 儲存溫度: −20°C

描述

一般說明

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs (+)-propoxyphene; aripiprazole; lacosamide; oxcarbazepine; rufinamide; and warfarin. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 象形圖: GHS02,GHS08,GHS07
• 訊號詞: Danger
• 危險聲明: H225,H302 + H312 + H332,H319,H360D,H373
• 防範說明: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P308 + P313
• 危險分類: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Repr. 1A - STOT RE 2
• 標靶器官: Blood
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: 35.6 °F - closed cup
• 閃點（°C）: 2.0 °C - closed cup